Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 24, 2026

Labeling and Imaging of Amyloid Plaques in Brain Tissue Using the Natural Polyphenol Curcumin
10:15

Labeling and Imaging of Amyloid Plaques in Brain Tissue Using the Natural Polyphenol Curcumin

Published on: November 1, 2019

Curcumin blocks brain tumor formation.

Sudarshana Purkayastha1, Alexandra Berliner, Suraj Shawn Fernando

  • 1Department of Chemistry, The College of Staten Island (CUNY), Staten Island, NY 10314, USA.

Brain Research
|April 17, 2009
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel Taxol-Derivative, STO-1, Induces Selective Anti-Tumor Immunity and Sustained Remission of Glioblastoma Without Triggering Autoimmune Reactions.

Cells·2025
Same author

One-Pot Synthesis of Phenylboronic Acid-Based Microgels for Tunable Gate of Glucose-Responsive Insulin Release at Physiological pH.

Molecules (Basel, Switzerland)·2025
Same author

Salutary effects of transdermal curcumin on multiple indices of health span in rodent models of normal aging and hypertension.

GeroScience·2025
Same author

Targeting sickle cell pathobiology and pain with novel transdermal curcumin.

PNAS nexus·2025
Same author

Corrigendum: Dietary polyphenols, resveratrol and pterostilbene exhibit antitumor activity on an HPV E6-positive cervical cancer model: an <i>in vitro</i> and <i>in vivo</i> analysis.

Frontiers in oncology·2024
Same author

Biocompatible Anisole-Nonlinear PEG Core-Shell Nanogels for High Loading Capacity, Excellent Stability, and Controlled Release of Curcumin.

Gels (Basel, Switzerland)·2023

Curcumin, a compound in turmeric, effectively blocks and eliminates brain tumors in mice. This soluble formulation crosses the blood-brain barrier, offering a potential new therapeutic strategy for brain cancer.

Area of Science:

  • Oncology
  • Neuroscience
  • Pharmacology

Background:

  • Turmeric contains curcumin, a polyphenol with demonstrated in vitro anti-tumor properties.
  • Previous research has not explored curcumin's in vivo anti-cancer activity in the brain.
  • Poor water solubility limits oral curcumin's effectiveness.

Purpose of the Study:

  • To investigate the efficacy of a soluble curcumin formulation in preventing and treating brain tumors in vivo.
  • To assess curcumin's ability to cross the blood-brain barrier and its effect on normal brain cells.
  • To elucidate the molecular mechanisms underlying curcumin's anti-brain tumor activity.

Main Methods:

  • Administration of a soluble curcumin formulation via tail vein and intracerebral injection in mice.

Related Experiment Videos

Last Updated: Jun 24, 2026

Labeling and Imaging of Amyloid Plaques in Brain Tissue Using the Natural Polyphenol Curcumin
10:15

Labeling and Imaging of Amyloid Plaques in Brain Tissue Using the Natural Polyphenol Curcumin

Published on: November 1, 2019

  • Assessment of normal brain cell viability post-curcumin treatment.
  • In vitro studies on human and mouse cancer cell lines to evaluate apoptosis and cell viability.
  • Analysis of key molecular targets including Cyclin D1, P-NF-kB, BclXL, P-Akt, and VEGF in B16F10 melanoma cells.
  • Main Results:

    • Soluble curcumin successfully crossed the blood-brain barrier without affecting normal brain cell viability.
    • Intracerebral injection of curcumin effectively blocked brain tumor formation in mice.
    • Curcumin induced apoptosis (caspase 3/7 activation) and reduced viability in various cancer cell lines.
    • Curcumin suppressed proliferation, survival, and invasion markers (Cyclin D1, P-NF-kB, BclXL, P-Akt, VEGF) in B16F10 cells.

    Conclusions:

    • Soluble curcumin is a promising agent for blocking and eliminating brain tumors in vivo.
    • Injectable curcumin formulations represent a potential safe therapeutic strategy for brain tumors.
    • Further research into curcumin's therapeutic application in neuro-oncology is warranted.